Rozenman Mary M.

Officer at Aimmune Therapeutics, Inc.

Sold, on record
$6.7M
Dollars the filings state
Form 4 sales
10
Latest Mar 1, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Nov 4, 2016 2016

    Sold 24,096 shares at $17.60 ($424k)

    Rozenman Mary M., Officer

    Sold 100% of holdings ($424k position)0 shares leftFiling

  2. 2 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jul 5, 2017 +243 days

    Sold 45,060 shares at $20.85 ($939k)

    Rozenman Mary M., Officer

    Sold 99.7% of holdings ($942k position)129 shares left1.8x usual sizeFiling

  3. 3 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jul 17, 2017 +12 days

    Sold 14,940 shares at $21.44 ($320k)

    Rozenman Mary M., Officer

    Sold 99.1% of holdings ($323k position)129 shares left0.5x usual sizeFiling

  4. 4 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Sep 7, 2017 +52 days

    Sold 30,000 shares at $22.50 ($675k)

    Rozenman Mary M., Officer

    Sold 99.6% of holdings ($678k position)129 shares left1.2x usual sizeFiling

  5. 5 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Dec 26, 2017 +110 days

    Sold 75,010 shares at $38.88 ($2.9M)

    Rozenman Mary M., Officer

    Sold 99.8% of holdings ($2.9M position)129 shares left2.7x usual sizeFiling

  6. 6 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jan 2, 2018 +7 days

    Sold 6,591 shares at $37.11 ($245k)

    Rozenman Mary M., Officer

    Sold 98.1% of holdings ($249k position)129 shares left0.2x usual sizeFiling

  7. 7 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Feb 1, 2018 +30 days

    Sold 6,592 shares at $35.36 ($233k)

    Rozenman Mary M., Officer

    Sold 98.1% of holdings ($238k position)129 shares left0.2x usual sizeFiling

  8. 8 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Mar 1, 2018 +28 days

    Sold 1,807 shares at $33.10 ($60k)

    Rozenman Mary M., Officer

    Sold 93.3% of holdings ($64k position)129 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Rozenman Mary M.
Source
Mar 1, 2018Mar 5, 2018Aimmune Therapeutics, Inc.OfficerForm 4 sale1,807$60k93.3%UnusualSEC
Feb 1, 2018Feb 5, 2018Aimmune Therapeutics, Inc.OfficerForm 4 sale6,592$233k98.1%UnusualSEC
Jan 2, 2018Jan 4, 2018Aimmune Therapeutics, Inc.OfficerForm 4 sale6,591$245k98.1%UnusualSEC
Dec 26, 2017Dec 28, 2017Aimmune Therapeutics, Inc.OfficerForm 4 sale75,010$2.9M99.8%UnusualSEC
Sep 7, 2017Sep 11, 2017Aimmune Therapeutics, Inc.OfficerForm 4 sale30,000$675k99.6%UnusualSEC
Jul 17, 2017Jul 17, 2017Aimmune Therapeutics, Inc.OfficerForm 4 sale14,940$320k99.1%UnusualSEC
Jul 5, 2017Jul 6, 2017Aimmune Therapeutics, Inc.OfficerForm 4 sale45,060$939k99.7%UnusualSEC
Nov 4, 2016Nov 4, 2016Aimmune Therapeutics, Inc.OfficerForm 4 sale24,096$424k100.0%UnusualSEC
Oct 5, 2016Oct 7, 2016Aimmune Therapeutics, Inc.OfficerForm 4 sale25,000$420k100.0%UnusualSEC
Sep 8, 2016Sep 9, 2016Aimmune Therapeutics, Inc.OfficerForm 4 sale30,000$504k100.0%UnusualSEC